Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2
Yoshinori Matsumoto, … , Ann Marie Pendergast, Robert Rottapel
Yoshinori Matsumoto, … , Ann Marie Pendergast, Robert Rottapel
Published October 31, 2016
Citation Information: J Clin Invest. 2016;126(12):4482-4496. https://doi.org/10.1172/JCI87802.
View: Text | PDF
Research Article Bone Biology Cell biology

Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2

  • Text
  • PDF
Abstract

Cellular identity in metazoan organisms is frequently established through lineage-specifying transcription factors, which control their own expression through transcriptional positive feedback, while antagonizing the developmental networks of competing lineages. Here, we have uncovered a distinct positive feedback loop that arises from the reciprocal stabilization of the tyrosine kinase ABL and the transcriptional coactivator TAZ. Moreover, we determined that this loop is required for osteoblast differentiation and embryonic skeletal formation. ABL potentiated the assembly and activation of the RUNX2-TAZ master transcription factor complex that is required for osteoblastogenesis, while antagonizing PPARγ-mediated adipogenesis. ABL also enhanced TAZ nuclear localization and the formation of the TAZ-TEAD complex that is required for osteoblast expansion. Last, we have provided genetic data showing that regulation of the ABL-TAZ amplification loop lies downstream of the adaptor protein 3BP2, which is mutated in the craniofacial dysmorphia syndrome cherubism. Our study demonstrates an interplay between ABL and TAZ that controls the mesenchymal maturation program toward the osteoblast lineage and is mechanistically distinct from the established model of lineage-specific maturation.

Authors

Yoshinori Matsumoto, Jose La Rose, Oliver A. Kent, Melany J. Wagner, Masahiro Narimatsu, Aaron D. Levy, Mitchell H. Omar, Jiefei Tong, Jonathan R. Krieger, Emily Riggs, Yaryna Storozhuk, Julia Pasquale, Manuela Ventura, Behzad Yeganeh, Martin Post, Michael F. Moran, Marc D. Grynpas, Jeffrey L. Wrana, Giulio Superti-Furga, Anthony J. Koleske, Ann Marie Pendergast, Robert Rottapel

×

Figure 6

TAZ reciprocally stabilizes and activates ABL through the suppression of a ubiquitin-mediated degradation pathway.

Options: View larger image (or click on image) Download as PowerPoint
TAZ reciprocally stabilizes and activates ABL through the suppression of...
(A) HEK293T cells were cotransfected with ABL, with or without Flag-TAZ. WCLs were probed with the indicated antibodies for Western blot analysis. (B) Primary murine osteoblasts from WT or Tazgt/gt (gt/gt) mice were cultured in osteogenic medium. WCLs were probed with the indicated antibodies for Western blot analysis. (C) Osteoblasts in B were cultured in osteogenic medium and stained with alizarin red S solution. n = 3. (D) HEK293T cells were cotransfected with ABL, with or without TAZ. 35S-labeled ABL protein was immunoprecipitated, separated by SDS-PAGE, and analyzed by autoradiography. The percentages of ABL protein levels are plotted as a function of time. (E) HEK293T cells cotransfected with the indicated constructs were treated with 10 μM MG132 for 4 hours prior to collection of cell lysates. ABL immune complexes were probed with an anti-HA or anti-ABL antibody. (F) HEK293T cells were cotransfected with HA-paxillin and Flag-TAZ, with or without ABL (WT or PP). HA-paxillin immune complexes were probed with an anti–p-Tyr antibody. (G) HEK293T cells were cotransfected with ABL and the indicated Flag-TAZ truncation mutant. WCLs were probed with the indicated antibodies for Western blot analysis. N, N-terminal; C, C-terminal. (H and I) HEK293T cells were cotransfected with ABL and either full-length TAZ [Flag-TAZ (WT)] or TAZ lacking the WW domain [Flag-TAZ (ΔWW)]. Flag-TAZ immune complexes (H) or WCLs (I) were probed with the indicated antibodies.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts